Weight Loss Clinic - Wegovy
Transform into a healthier, fitter version of yourself with our weight loss clinic. We provide personalized services tailored to your specific needs and health requirements.
Wegovy
Wegovy is a prescription-only weight loss injection containing the active ingredient Semaglutide. It is injected into the body once a week to help lose weight in patients, in conjunction with a reduced-calorie diet and increased physical activity.
Indication
To reduce weight in obese patients with an initial Body Mass Index (BMI) of ≥ 30 kg/m2 or overweight patients with BMI ≥27 kg/m2 to <30 kg/m2 and at least one weight-related comorbidity.
Inclusion Criteria
Valid consent has been obtained from the patient/carer who does not want to consult with their GP and would prefer to access treatment from the PGD user.
- Patients aged between 18 and 74 years.
- Patients with an initial BMI of 30 kg/m2 or greater.
- Patients in which a supervised diet, behaviour modification and increasing physical activity failed to achieve a realistic reduction in weight.
- Patients with an initial BMI of 27 kg/m2 or greater with at least one weight-related comorbidity, including but not limited to:
- Hypertension
- Dyslipidaemia
- Obstructive sleep apnoea
- Type 2 diabetes mellitus
Healthcare professionals must be able to justify the decision to supply Wegovy to patients with a BMI ≥27 kg/m2 to <30kg/m². The patient must have a health condition that is either caused or exacerbated by their weight, and that is likely to be either resolved or improved by weight loss.
